Abstract
A highly purified gel electrophoretic fraction of murine leukemia virus (MuLV) can confer enhanced infectivity on MuLV derived from tissue culture and can protect MuLV from neutralization by specific antiserum. Of the known viral proteins tested, a purified electrophoretic fraction (14,000 daltons) is the only active fraction and seems to consist of the group-specific antigen I and an associated lipid moiety. The action of this fraction obtained from one type of MuLV is group-specific in that it can enhance and protect serologically different types of MuLV. The effect of this fraction is exerted on viruses and not on cells. MuLV derived from tumors was not enhanced by the fraction, but became amenable to its action after a single passage through tissue culture. Reconstruction experiments suggested that the fraction may consist of an exterior protein associated with some lipids. This complex, which apparently protrudes on the viral surface, is required for infectivity and shields the type-specific antigen containing the hemagglutinating site.
Keywords: virus antigens, group-specific antigen I
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bassin R. H., Tuttle N., Fischinger P. J. Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer. 1970 Jul 15;6(1):95–107. doi: 10.1002/ijc.2910060114. [DOI] [PubMed] [Google Scholar]
- Bassin R. H., Tuttle N., Fischinger P. J. Rapid cell culture assay technic for murine leukaemia viruses. Nature. 1971 Feb 19;229(5286):564–566. doi: 10.1038/229564b0. [DOI] [PubMed] [Google Scholar]
- Bolognesi D. P., Bauer H. Polypeptides of avian RNA tumor viruses. 1. Isolation and physical and chemical analysis. Virology. 1970 Dec;42(4):1097–1112. doi: 10.1016/0042-6822(70)90357-0. [DOI] [PubMed] [Google Scholar]
- Duc-Nguyen H. Enhancing effect of diethylaminoethyl-dextran on the focus-forming titer of a murine sarcoma virus (Harvey strain). J Virol. 1968 Jun;2(6):643–644. doi: 10.1128/jvi.2.6.643-644.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duesberg P. H., Martin G. S., Vogt P. K. Glycoprotein components of avian and murine RNA tumor viruses. Virology. 1970 Aug;41(4):631–646. doi: 10.1016/0042-6822(70)90428-9. [DOI] [PubMed] [Google Scholar]
- Fink M. A., Sibal L. R., Wivel N. A., Cowles C. A., O'Conner T. E. Some characteristics of an isolated group antigen common to most strains of murine leukemia virus. Virology. 1969 Apr;37(4):605–614. doi: 10.1016/0042-6822(69)90278-5. [DOI] [PubMed] [Google Scholar]
- Fischinger P. J., Moore C. O., O'Connor T. E. Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. J Natl Cancer Inst. 1969 Apr;42(4):605–622. [PubMed] [Google Scholar]
- Geering G., Aoki T., Old L. J. Shared viral antigen of mammalian leukaemia viruses. Nature. 1970 Apr 18;226(5242):265–266. doi: 10.1038/226265a0. [DOI] [PubMed] [Google Scholar]
- Geering G., Hardy W. D., Jr, Old L. J., de Harven E., Brodey R. S. Shared group-specific antigen of murine and feline leukemia viruses. Virology. 1968 Dec;36(4):678–680. doi: 10.1016/0042-6822(68)90199-2. [DOI] [PubMed] [Google Scholar]
- Geering G., Old L. J., Boyse E. A. Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med. 1966 Oct 1;124(4):753–772. doi: 10.1084/jem.124.4.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gregoriades A., Old L. J. Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses. Virology. 1969 Feb;37(2):189–202. doi: 10.1016/0042-6822(69)90198-6. [DOI] [PubMed] [Google Scholar]
- Moroni C. Structural proteins of Rauscher leukemia virus and Harvey sarcoma virus. Virology. 1972 Jan;47(1):1–7. doi: 10.1016/0042-6822(72)90232-2. [DOI] [PubMed] [Google Scholar]
- Oroszlan S., Foreman C., Kelloff G., Gilden R. V. The group-specific antigen and other structural proteins of hamster and mouse C-type viruses. Virology. 1971 Mar;43(3):665–674. doi: 10.1016/0042-6822(71)90290-x. [DOI] [PubMed] [Google Scholar]
- Rifkin D., Compans R. W. Identification of the spike proteins of Rous sarcoma virus. Virology. 1971 Nov;46(2):485–489. doi: 10.1016/0042-6822(71)90049-3. [DOI] [PubMed] [Google Scholar]
- Schlom J., Moloney J. B., Groupé V. Evidence for the rapid decrease in leukemogenic potential Rauscher leukemia virus in cell culture. Cancer Res. 1971 Mar;31(3):260–264. [PubMed] [Google Scholar]
- Schäfer W., Anderer F. A., Bauer H., Pister L. Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen. Virology. 1969 Jul;38(3):387–394. doi: 10.1016/0042-6822(69)90151-2. [DOI] [PubMed] [Google Scholar]
- Schäfer W., Fischinger P. J., Lange J., Pister L. Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology. 1972 Jan;47(1):197–209. doi: 10.1016/0042-6822(72)90252-8. [DOI] [PubMed] [Google Scholar]
- Schäfer W., Lange J., Fischinger P. J., Frank H., Bolognesi D. P., Pister L. Properties of mouse leukemia viruses. II. Isolation of viral components. Virology. 1972 Jan;47(1):210–228. doi: 10.1016/0042-6822(72)90253-x. [DOI] [PubMed] [Google Scholar]
- Schäfer W., Szántó J. Studies on Mouse Leukemia Viruses. II. Nachweis eines virusspezifischen Hämagglutinins. Z Naturforsch B. 1969 Oct;24(10):1324–1331. [PubMed] [Google Scholar]

